A science advisory from the American Heart Association recommended that prescription n-3 fatty acids (eicosapentaenoic acid [EPA]+docosahexaenoic acid [DHA] or EPA-only) at a dose of 4 g/d (>3 g/d total EPA+DHA) are an effective and safe option for reducing triglycerides as monotherapy or as an adjunct to other lipid-lowering agents (https://www.ahajournals.org/). AstraZeneca announced that compared to placebo, dapagliflozin (a SGLT2 inhibitor) significantly reduced cardiovascular death or the worsening of heart failure (HF, defined as hospitalization or an urgent HF visit) in patients with and without type 2 diabetes with reduced ejection fraction on standard of care treatment (https://www.astrazeneca-us.com/). Data from a US community‐based cohort of 12 168 middle‐aged adults suggest that diets higher in plant foods and lower in animal foods were associated with a lower risk of cardiovascular morbidity and mortality in a general population (https://www.ahajournals.org/).
A circadian subtype of depression is associated with earlier disease onset, more severe clinical features,…
A longitudinal study of 995 U.S. older adults found that frequent and unintentional daytime napping…
A multicohort genetic association study found that the ancestry-enriched CD36 Y325* variant accounted for a…
An American College of Cardiology scientific statement emphasizes that exercise should be prescribed as a…
A 16-week low-fat vegan diet was associated with significant reductions in body weight, visceral fat,…
A systematic review and meta-analysis of 27 studies involving 88,830 participants found that intensive blood…
This website uses cookies.